COMMUNIQUÉS West-GlobeNewswire
-
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
16/09/2026 -
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
16/09/2026 -
NurExone Announces Voting Results of Annual General and Special Meeting of Shareholders and Provides Corporate Update
16/09/2026 -
Avalyn Appoints Robert J. Meyer, MD, to its Board of Directors
16/09/2026 -
Tiderock Companies, Inc. to Become Aloros Corporation, Sharpening Strategic Focus on Advanced Manufacturing
16/09/2026 -
Jack Ady Cancer Centre launches Alberta's first researcher-led cancer clinical trial outside major urban centres
16/09/2026 -
San Francisco First Responders Report Fewer Nightmares in New NightWare Study
16/09/2026 -
Eurobio Scientific: EB Development, actionnaire majoritaire d’Eurobio Scientific, annonce son intention de déposer une offre publique de retrait suivie d'un retrait obligatoire, au prix de 25,30 € par action
16/09/2026 -
Thirty Inspiring Middle School Scientists and Engineers Named Finalists in the 2026 Thermo Fisher Scientific Junior Innovators Challenge
16/09/2026 -
TwitchView® Selected by Two Additional Top 10 U.S. Children's Hospitals for Quantitative Neuromuscular Monitoring
16/09/2026 -
Ignitus Recovery Announces Acquisition of AIM Health: Building on a 20-Year Legacy
16/09/2026 -
NADP Foundation Issues Request for Proposals
16/09/2026 -
Horse Peak Gelatin Launch 2026: Natural Vitality Formula For Men Read HorsePeak Gummies Supplement Facts & Ingredients Highlights
16/09/2026 -
Avacta Achieves Clinical Proof of Mechanism for the Next Generation of pre|CISION® Medicines with AVA6103 (FAP-Exd) in the Phase 1 FOCUS-01 Trial
16/09/2026 -
TerrAscend Strengthens Leadership Position in New Jersey with Closing of Aunt Mary’s Transaction
16/09/2026 -
Dr. Peter Goldman Returns to the Bay Area, Bringing Zone Technique and a Distinct Approach to Healing to Berkeley, CA
16/09/2026 -
X-Chem Named First Winner of Chordoma Foundation TBXT Challenge with Discovery of Novel Binder for Untreatable Bone Cancer Target
16/09/2026 -
NEXGEL Announces Date for Investor Update Call
16/09/2026 -
PETVIVO ANIMAL HEALTH, INC. RELEASES CONFERENCE AND EXHIBIT SCHEDULE FOR 2026-2027
16/09/2026
Pages